Work

YY1: A Master Regulator at the Crossroads of Targeted Cancer Therapy - A Commentary

Year: 2025

Type: article

Abstract: Our recent publication entitled “YY1 downregulation underlies therapeutic response to molecular targeted agents” represents a significant advancement in our understanding of the molecular mechanisms governing drug resistance in oncogene-addicted cancers [1].

Source: Addiction & Addictive Disorders

DOI: 10.24966/aad-7276/100199

Author: Junhong Jiang

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4413331310

FWCI:

Cites:

Cited by:

Related to: 10